We can hypothesise that the increased risk of cardiac malformations in women with insulin-treated GDM may be partly associated with maternal obesity, although maternal BMI was not recorded in the national database used for this study. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.